Stijn E. Verleden
← Back to University of Antwerp
University of Antwerp
Stijn E. Verleden works in Transplantation: Methods and Outcomes, Organ Transplantation Techniques and Outcomes, Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Chronic Obstructive Pulmonary Disease (COPD) Research, Renal Transplantation Outcomes and Treatments. Recorded institutional associations include University of Antwerp, Antwerp University Hospital, KU Leuven.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
2020 · 5,589 citationsChronic lung allograft dysfunction: Definition and update of restrictive allograft syndrome―A consensus report from the Pulmonary Council of the ISHLT
2019 · 302 citationsA randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation
2010 · 268 citationsInhibition of LTβR signalling activates WNT-induced regeneration in lung
2020 · 179 citationsTranscriptional regulatory model of fibrosis progression in the human lung
2019 · 174 citationsThe arginine methyltransferase PRMT7 promotes extravasation of monocytes resulting in tissue injury in COPD
2022 · 128 citationsChronic lung allograft dysfunction phenotypes and treatment
2017 · 125 citationsSmall airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study
2020 · 125 citationsImpact of CLAD Phenotype on Survival After Lung Retransplantation: A Multicenter Study
2015 · 124 citationsSurvival Determinants in Lung Transplant Patients With Chronic Allograft Dysfunction
2011 · 118 citationsBronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome
2013 · 115 citationsAnti-Inflammatory and Immunomodulatory Properties of Azithromycin Involved in Treatment and Prevention of Chronic Lung Allograft Rejection
2012 · 105 citationsThe impact of traffic air pollution on bronchiolitis obliterans syndrome and mortality after lung transplantation
2011 · 101 citationsDonor-specific and -nonspecific HLA antibodies and outcome post lung transplantation
2017 · 100 citationsInternational Society for Heart and Lung Transplantation consensus statement for the standardization of bronchoalveolar lavage in lung transplantation
2020 · 100 citationsInnate and Adaptive Interleukin-17–producing Lymphocytes in Chronic Inflammatory Lung Disorders
2010 · 99 citationsLong-term azithromycin therapy for bronchiolitis obliterans syndrome: Divide and conquer?
2010 · 96 citationsAnalysis of airway pathology in COPD using a combination of computed tomography, micro-computed tomography and histology
2018 · 96 citationsAltered generation of ciliated cells in chronic obstructive pulmonary disease
2019 · 96 citationsImpact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis: a retrospective cohort study
2020 · 93 citationsCurrent views on chronic rejection after lung transplantation
2015 · 92 citationsThe Site and Nature of Airway Obstruction after Lung Transplantation
2014 · 91 citationsProphylactic Azithromycin Therapy After Lung Transplantation: Post hoc Analysis of a Randomized Controlled Trial
2015 · 89 citationsAge-related differences in metabolites in the posterior cingulate cortex and hippocampus of normal ageing brain: A 1H-MRS study
2011 · 87 citationsThe role of miR-155 in cigarette smoke-induced pulmonary inflammation and COPD
2019 · 87 citations
